chevron_left
Navigating unexpected toxicities with data-driven insights
Unexpected toxicities can derail even the most promising drug candidates. With OFF-X, gain powerful translational safety intelligence to stay ahead of risk.
Monitor related drugs within the same class as your asset to uncover safety patterns, detect emerging adverse events, and identify biological pathways that may signal toxicity risks before they become trial-stopping problems.
In this case study, OFF-X helped identify downstream liver toxicity risks in a CCR4 antagonist, leading to new hypotheses and targeted safety strategies after a Phase 2 discontinuation.
- Daily safety updates from trusted data sources
- Visual pathway mapping to uncover upstream/downstream risks
- Comparative safety profiles to support smarter R&D decisions
Read the full case study now.